Effect of allogeneic pure platelet-rich plasma, sodium cloxacillin, and their combination for the treatment of subclinical mastitis in crossbred cows

被引:0
|
作者
Lopez, Catalina [1 ]
Duque-Madrid, Paulo Cesar [2 ]
Ceballos-Marquez, Alejandro [2 ]
Carmona, Jorge U. [3 ]
机构
[1] Univ Caldas, Dept Salud Anim, Grp Invest Patol Clin Vet, Manizales, Colombia
[2] Univ Caldas, Dept Prod Agr, Grp Invest Cal Leche & Epidemiol Vet, Manizales, Colombia
[3] Univ Caldas, Dept Salud Anim, Grp Invest Terapia Regenerat, Manizales, Colombia
关键词
platelet-rich plasma; bovine; subclinical mastitis; gram-positive bacteria; growth factors; cytokines; SOMATIC-CELL COUNT; INTRACELLULAR STAPHYLOCOCCUS-AUREUS; BOVINE ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; CYTOKINES TNF-ALPHA; NF-KAPPA-B; ECONOMIC-IMPACT; MILK-YIELD; THERAPY; CURE;
D O I
10.3389/fvets.2024.1432354
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Introduction: Bovine subclinical mastitis (SCM) caused by Gram-positive bacteria is a major cause of economic loss in the dairy industry, exacerbated in situations where antimicrobial resistance is present. Pure platelet-rich plasma (P-PRP) may be a therapeutic alternative for SCM, when used alone or with antibiotics, such as sodium cloxacillin (SC). This study aimed 1) to evaluate the therapeutic efficacy of allogeneic P-PRP, SC, and their combination (P-PRP+SC) in cows with SCM caused by Staphylococcus aureus and by streptococci (Staphylococcus aureus and S. dysgalactiae); 2) to determine the concentrations of somatic cells (SCC), interleukin 1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and TGF-beta(1) in milk samples of the cows. Methods: 130 cows from 4 dairy herds completed the study, of which 40 cows were treated with P-PRP (10 mL), 28 cows with SC (5g), 36 with P-PRP+SC (10mL/5g), and 26 did not receive no treatment (negative control group, NCG). Results: The overall bacteriological cure was observed in 10/40 (25%) cows in the P-PRP group, 9/28 (32.14%) animals in the SC group, 26/36 (72.22%) cows in the P-PRP+SC group, and 10/26 (38.46%) animals in the NCG. SCM caused by S. aureus (82/130, 63.08%), was cured in 6/24 (25%) cows treated with P-PRP, 7/24 (29.2%) cows treated with SC, 8/16 (50%) animals treated with P-PRP+SC, and in 8/18 (44.4%) cows in NCG. For SCM caused by the streptococci (48/130, 36.91%), the cure was achieved in 4/12 (33.3%) cows treated with P-PRP, 2/4 (50%) cows treated with SC, 18/20 (90%) cows treated with P-PRP+SC, and in 2/8 (25%) cows of the NCG. SCC was significantly (p < 0.001) affected by the treatment, herd, cure, bacteria group, and number of calvings factors. IL-1 beta milk concentrations were significantly (p < 0.001) influenced by treatment and farm factors, and the interaction between these factors. TNF-alpha milk concentrations were significantly (p < 0.001) influenced by time factor. TGF-beta(1) milk concentrations were significantly affected by the time and cure factors. Conclusion: The combination of P-PRP and SC showed the best therapeutic response (90%) against bovine SCM caused by streptococci. However, none of the treatments showed an effective therapeutic response against S. aureus.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The effect of platelet-rich plasma in the treatment of external humeral epicondylitis and an analysis of the influencing factors
    Jiang, Wenxiao
    Zhuang, Jian
    Zhang, Yijun
    Gao, Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (06): : 3866 - 3874
  • [32] Effect of platelet-rich plasma and microfracture reparative technique combined in chondral lesions treatment
    Zedde, Pietro
    Cudoni, Sebastian
    Lisai, Pietro
    Fadda, Mario
    Manunta, Andrea Fabio
    JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 2015, 88 (02): : 162 - 165
  • [33] Use of Platelet-Rich Plasma as a Regenerative Therapy for In-Vitro Embryo Production and Treatment of Repeat Breeding in Cows
    Ahmed Hassaneen, Ahmed Saad
    Rawy, Mohamed Sadawy
    Yamanokuchi, Eigo
    Elgendy, Omnia
    Kawano, Takanori
    Wakitani, Shoichi
    Kitahara, Go
    Osawa, Takeshi
    SSRN, 2023,
  • [34] The effects of a combination treatment with mesenchymal stem cell and platelet-rich plasma on tendon healing: an experimental study
    Uyar, Ilker
    Altuntas, Zeynep
    Findik, Siddika
    Yildirim, Mehmet Emin Cem
    Yarar, Serhat
    Aktan, Murat
    Avci, Alunet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 237 - 247
  • [35] The combination of platelet-rich plasma with botulinum toxin A in the treatment of hyaluronic acid embolic cutaneous necrosis and alopecia
    Guo, Yanping
    Wei, Wuhan
    Zhang, Aijun
    Tao, Changbo
    Li, Xueyang
    Wang, Ji
    Li, Qiang
    Jin, Peisheng
    DERMATOLOGIC THERAPY, 2022, 35 (06)
  • [36] The Potential Use of Allogeneic Platelet-Rich Plasma for Large Bone Defect Treatment: Immunogenicity and Defect Healing Efficacy
    Zhang, Zhi-Yong
    Huang, Ai-Wen
    Fan, Jun Jun
    Wei, Kuanhai
    Jin, Dan
    Chen, Bin
    Li, Dan
    Bi, Long
    Wang, Jun
    Pei, Guoxian
    CELL TRANSPLANTATION, 2013, 22 (01) : 175 - 187
  • [37] Successful Treatment of Chronic Lower Extremity Ulcers with Allogeneic Platelet-Rich Plasma and Artificial Dermis: A Case Report
    Zhao, Qiannan
    Ma, Yuanyuan
    Lu, Yuquan
    Chai, Yuan
    Zhou, Yuemin
    ADVANCES IN SKIN & WOUND CARE, 2019, 32 (12) : 550 - 552
  • [38] Allogeneic Platelet-Rich Plasma Versus Corticosteroid Injection for the Treatment of Rotator Cuff Disease A Randomized Controlled Trial
    Jo, Chris Hyunchul
    Lee, Seung Yeon
    Yoon, Kang Sup
    Oh, Sohee
    Shin, Sue
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2020, 102 (24): : 2129 - 2137
  • [39] Striae Distensae: In Vitro Study and Assessment of Combined Treatment with Sodium Ascorbate and Platelet-Rich Plasma on Fibroblasts
    Dong, Xinhang
    Zhang, Mingzi
    Jin, Xiaolei
    AESTHETIC PLASTIC SURGERY, 2022, 46 (01) : 559 - 560
  • [40] Striae Distensae: In Vitro Study and Assessment of Combined Treatment with Sodium Ascorbate and Platelet-Rich Plasma on Fibroblasts
    Xinhang Dong
    Mingzi Zhang
    Xiaolei Jin
    Aesthetic Plastic Surgery, 2022, 46 : 559 - 560